Literature DB >> 11890877

Raynaud's phenomenon: epidemiology and risk factors.

Liana Fraenkel1.   

Abstract

Although originally described more than 100 years ago, the pathophysiology of Raynaud's phenomenon (RP) remains incompletely understood. Epidemiologic studies have the potential to improve our understanding of the pathogenesis of RP and to identify potential targets for therapeutic interventions. Such studies require standardized instruments to accurately identify subjects with RP. Dr. Maricq was the first to develop and validate a standardized instrument to classify patients with this disorder. Her work has facilitated many of the epidemiologic studies of RP that are discussed in this review.

Entities:  

Mesh：

Year:  2002        PMID： 11890877     DOI： 10.1007/s11926-002-0007-z

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  56 in total

1.  A two-stage, genome-wide screen for susceptibility loci in primary Raynaud's phenomenon.

Authors:  E Susol; A J MacGregor; J H Barrett; H Wilson; C Black; K Welsh; A Silman; B Ollier; J Worthington
Journal:  Arthritis Rheum       Date:  2000-07

2.  alpha Adrenoreceptors but not beta adrenoreceptors increase in rabbit uterus with oestrogen.

Authors:  J M Roberts; P A Insel; R D Goldfien; A Goldfien
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

3.  Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison.

Authors:  H R Maricq; P H Carpentier; M C Weinrich; J E Keil; Y Palesch; C Biro; M Vionnet-Fuasset; M Jiguet; I Valter
Journal:  J Rheumatol       Date:  1997-05       Impact factor: 4.666

4.  Prevalence of symptoms of Raynaud's phenomenon in general practice.

Authors:  A Silman; S Holligan; P Brennan; P Maddison
Journal:  BMJ       Date:  1990-09-22

5.  Association between cigarette and alcohol consumption and Raynaud's phenomenon.

Authors:  Y Y Palesch; I Valter; P H Carpentier; H R Maricq
Journal:  J Clin Epidemiol       Date:  1999-04       Impact factor: 6.437

6.  Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon.

Authors:  A D Blann; K Illingworth; M I Jayson
Journal:  J Rheumatol       Date:  1993-08       Impact factor: 4.666

7.  An epidemiological survey of Raynaud's phenomenon.

Authors:  J C de Trafford; K Lafferty; C E Potter; V C Roberts; L T Cotton
Journal:  Eur J Vasc Surg       Date:  1988-06

8.  The association of estrogen replacement therapy and the Raynaud phenomenon in postmenopausal women.

Authors:  L Fraenkel; Y Zhang; C E Chaisson; S R Evans; P W Wilson; D T Felson
Journal:  Ann Intern Med       Date:  1998-08-01       Impact factor: 25.391

9.  Cold-induced potentiation of alpha 2-adrenergic vasoconstriction in primary Raynaud's disease.

Authors:  R R Freedman; M Moten; P Migály; M Mayes
Journal:  Arthritis Rheum       Date:  1993-05

10.  Color chart assisted diagnosis of Raynaud's phenomenon in an unselected hospital employee population.

Authors:  S T O'Keeffe; N P Tsapatsaris; W P Beetham
Journal:  J Rheumatol       Date:  1992-09       Impact factor: 4.666
View more
  10 in total

1.  Raynaud's phenomenon: prevalence in an Italian population sample.

Authors:  Rossella De Angelis; Fausto Salaffi; Walter Grassi
Journal:  Clin Rheumatol       Date:  2005-11-15       Impact factor: 2.980

2.  Sex differences influencing micro- and macrovascular endothelial phenotype in vitro.

Authors:  Virginia H Huxley; Scott S Kemp; Christine Schramm; Steve Sieveking; Susan Bingaman; Yang Yu; Isabella Zaniletti; Kevin Stockard; Jianjie Wang
Journal:  J Physiol       Date:  2018-07-15       Impact factor: 5.182

3.  Raynaud's phenomenon in Northern Sweden: a population-based nested case-control study.

Authors:  Albin Stjernbrandt; Hans Pettersson; Ingrid Liljelind; Tohr Nilsson; Jens Wahlström
Journal:  Rheumatol Int       Date:  2018-08-20       Impact factor: 2.631

4.  Nipple pain, damage, and vasospasm in the first 8 weeks postpartum.

Authors:  Miranda L Buck; Lisa H Amir; Meabh Cullinane; Susan M Donath
Journal:  Breastfeed Med       Date:  2013-12-31       Impact factor: 1.817

5.  Noninvasive evaluation of cardiac autonomic modulation in children with primary Raynaud’s phenomenon: a controlled study.

Authors:  Mehmet Burhan Oflaz; İbrahim Ece; Ayşe Esin Kibar; Şevket Ballı; Demet Alaygut; Ahmet Sami Guven; Fatih Bolat; Fatma Duksal; Ömer Cevit
Journal:  Clin Rheumatol       Date:  2014-01       Impact factor: 2.980

6.  The association of Raynaud's syndrome with rheumatoid arthritis--a meta-analysis.

Authors:  Peter Hartmann; Melvin Mohokum; Peter Schlattmann
Journal:  Clin Rheumatol       Date:  2011-04-02       Impact factor: 2.980

Review 7.  The association of Raynaud's syndrome with carpal tunnel syndrome: a meta-analysis.

Authors:  Peter Hartmann; Melvin Mohokum; Peter Schlattmann
Journal:  Rheumatol Int       Date:  2011-09-07       Impact factor: 2.631

8.  Postocclusive Hyperemia Measured with Laser Doppler Flowmetry and Transcutaneous Oxygen Tension in the Diagnosis of Primary Raynaud's Phenomenon: A Prospective, Controlled Study.

Authors:  Paweł Maga; Brandon Michael Henry; Elizabeth K Kmiotek; Iwona Gregorczyk-Maga; Paweł Kaczmarczyk; Krzysztof A Tomaszewski; Rafał Niżankowski
Journal:  Biomed Res Int       Date:  2016-12-22       Impact factor: 3.411

Review 9.  Raynaud's Phenomenon: Reviewing the Pathophysiology and Management Strategies.

Authors:  Iqra Nawaz; Yashfa Nawaz; Eisha Nawaz; Muhammad Romail Manan; Adil Mahmood
Journal:  Cureus       Date:  2022-01-28

10.  Clinical features and risk factors of Raynaud's phenomenon in primary Sjögren's syndrome.

Authors:  Wei Lin; Zhifei Xin; Xiaoran Ning; Yang Li; Xiuying Ren; Yashuang Su; Meilu Liu; Shaoying Guo; Liu Yang; Yixuan Liu; Fengxiao Zhang; Wen Zhang
Journal:  Clin Rheumatol       Date:  2021-04-29       Impact factor: 2.980
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.